DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Katugampola SD, Davenport AP.
Thromboxane receptor density is increased in human cardiovascular disease with evidence for inhibition at therapeutic concentrations by the AT(1) receptor antagonist losartan.
Br J Pharmacol 2001;
134: 1385-1392.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.